K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy

被引：4
作者：
Turaga, Kiran [1 ]
Shibata, David [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Oncol, Tampa, FL 33682 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷 / 02期
关键词：
TUMOR MICROSATELLITE-INSTABILITY; COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; KRAS; FLUOROURACIL; MUTATIONS; SURVIVAL; PREDICT; STAGE;
D O I：
10.1245/s10434-009-0712-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：354 / 355
页数：2
相关论文
共 12 条
  • [1] Ahnen DJ, 1998, CANCER RES, V58, P1149
  • [2] Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
    Amado, Rafael G.
    Wolf, Michael
    Peeters, Marc
    Van Cutsem, Eric
    Siena, Salvatore
    Freeman, Daniel J.
    Juan, Todd
    Sikorski, Robert
    Suggs, Sid
    Radinsky, Robert
    Patterson, Scott D.
    Chang, David D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1626 - 1634
  • [3] Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
    Bertagnolli, Monica M.
    Niedzwiecki, Donna
    Compton, Carolyn C.
    Hahn, Hejin P.
    Hall, Margaret
    Damas, Beatrice
    Jewell, Scott D.
    Mayer, Robert J.
    Goldberg, Richard M.
    Saltz, Leonard B.
    Warren, Robert S.
    Redston, Mark
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1814 - 1821
  • [4] Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
    Des Guetz, Gaetan
    Schischmanoff, Olivier
    Nicolas, Patrick
    Perret, Gerard-Yves
    Morere, Jean-Francois
    Uzzan, Bernard
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) : 1890 - 1896
  • [5] Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
    Gryfe, R
    Kim, H
    Hsieh, ETK
    Aronson, MD
    Holowaty, EJ
    Bull, SB
    Redston, M
    Gallinger, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02) : 69 - 77
  • [6] KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
    Lievre, Astrid
    Bachet, Jean-Baptiste
    Boige, Valerie
    Cayre, Anne
    Le Corre, Delphine
    Buc, Emmanuel
    Ychou, Marc
    Bouche, Olivier
    Landi, Bruno
    Louvet, Christophe
    Andre, Thierry
    Bibeau, Frederic
    Diebold, Marie-Daniele
    Rougier, Philippe
    Ducreux, Michel
    Tomasic, Gorana
    Emile, Jean-Francois
    Penault-Llorca, Frederique
    Laurent-Puig, Pierre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 374 - 379
  • [7] KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
    Nash, Garrett M.
    Gimbel, Mark
    Shia, Jinru
    Nathanson, Daniel R.
    Ndubuisi, MacKevin I.
    Zeng, Zhao-Shi
    Kemeny, Nancy
    Paty, Philip B.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 572 - 578
  • [8] KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer
    Nash, Garrett M.
    Gimbel, Mark
    Cohen, Alfred M.
    Zeng, Zhao-Shi
    Ndubuisi, Mackevin I.
    Nathanson, Daniel R.
    Ott, Jurg
    Barany, Francis
    Paty, Philip B.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 416 - 424
  • [9] Association of Progression-free Survival, Overall Survival, and Patient-reported Outcomes by Skin Toxicity and KRAS Status in Patients Receiving Panitumumab Monotherapy
    Peeters, Marc
    Siena, Salvatore
    Van Cutsem, Eric
    Sobrero, Alberto
    Hendlisz, Alain
    Cascinu, Stefano
    Kalofonos, Haralabos
    Devercelli, Giovanna
    Wolf, Michael
    Amado, Rafael G.
    [J]. CANCER, 2009, 115 (07) : 1544 - 1554
  • [10] Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
    Ribic, CM
    Sargent, DJ
    Moore, MJ
    Thibodeau, SN
    French, AJ
    Goldberg, RM
    Hamilton, SR
    Laurent-Puig, P
    Gryfe, R
    Shepherd, LE
    Tu, D
    Redston, M
    Gallinger, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03) : 247 - 257
12